Gram-Negative Bacterial Lysins

Area of Science:

• Microbiology
• Biotechnology
• Infectious Diseases

Background:

• Antibiotic resistance is a major global health threat due to widespread use and overuse of conventional antibiotics.
• Bacteriophage endolysins (lysins) are enzymes that degrade bacterial cell walls, offering a potential alternative to antibiotics.
• Lysins exhibit unique properties making them suitable for combating multidrug-resistant bacterial pathogens.

Purpose of the Study:

• To review newly discovered classes of Gram-negative lysins.
• To emphasize prototypical enzymes effective against major antibiotic-resistant organisms causing nosocomial infections.
• To highlight the potential of lysins as novel antimicrobial agents.

Main Methods:

• Review of scientific literature on bacteriophage endolysins.
• Focus on enzymes targeting Gram-negative bacteria.
• Evaluation of lysin efficacy against antibiotic-resistant pathogens.

Main Results:

• Lysins are rapidly acting antimicrobials that cleave bacterial cell walls, leading to bacterial death within seconds.
• Resistance to lysins is significantly less likely compared to conventional antibiotics due to their targeted mechanism.
• Newly discovered lysins show efficacy against major antibiotic-resistant organisms responsible for hospital-acquired infections.

Conclusions:

• Lysins represent a promising therapeutic strategy to address the challenge of antibiotic resistance.
• Engineered or naturally occurring lysins can be developed into fast-acting, narrow-spectrum antimicrobials.
• Lysins have the potential to disrupt biofilms and act synergistically with existing antibiotics.